NL-OMON34286
Withdrawn
Phase 3
Beyond conventional treatment of Atopic eczema in infants: Management By specific prObiOtic strains. A double blind placebo-controlled trial. - the BAMBOO study
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- allergy
- Sponsor
- Sint Antonius Ziekenhuis
- Enrollment
- 120
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 0\-15 months
- •atopic dermatitis for at least 2 weeks, with SCORAD score 15\-50
Exclusion Criteria
- •class II or higher class topical corticosteroid use, or use of systemic corticosteroids
- •antibiotic treatment just before enrollment or in the first week of the study
- •syndromal abnormalities, major medical problems
- •lack of knowledge of the Dutch language
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Better control and treatment of Atopic Dermatitis disease by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsieseczematopic dermatitis10014982NL-OMON51252Radboud Universitair Medisch Centrum60
Recruiting
Phase 1
Optimization of atopic dermatitis treatment that requires second-line systemic therapy through multiomic predictive models of treatment response (DermAtOmics-II)Atopic dermatitisTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]CTIS2023-506165-62-00Hospital Universitario La Paz150
Active, not recruiting
Phase 1
EO19123 Cream in the Treatment of Atopic Dermatitis A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of atopic dermatitis - LEO19123 Cream in the Treatment of Atopic DermatitisAtopic dermatitisMedDRA version: 8.1 Level: LLT Classification code 10003639 Term: Atopic dermatitisEUCTR2006-001472-20-GBEO Pharmaceutical Products Ltd A/S (LEO Pharma A/S)75
Active, not recruiting
Phase 1
EO19123 Cream in the Treatment of Atopic DermatitisA Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of atopic dermatitis - LEO19123 Cream in the Treatment of Atopic DermatitisEUCTR2006-001472-20-DKEO Pharma A/S75
Active, not recruiting
Not Applicable
EO19123 Cream in the Treatment of Atopic DermatitisA Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of atopic dermatitis - LEO19123 Cream in the Treatment of Atopic DermatitisAtopic dermatitisMedDRA version: 8.1Level: LLTClassification code 10003639Term: Atopic dermatitisEUCTR2006-001472-20-FIEO Pharma A/S75